Astria Therapeutics, Inc.

NASDAQ:ATXS

6.45 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018201720162015201420132012
Revenue 00000000.500000
Cost of Revenue 000000.0260.11900.3950.202000
Gross Profit 00000-0.026-0.1190.5-0.395-0.202000
Gross Profit Ratio 0000000100000
Reseach & Development Expenses 77.10657.32634.26415.55225.5918.31717.04218.68225.4523.0315.68613.9940.012
General & Administrative Expenses 34.45225.70419.23914.80711.8458.7719.3298.91210.1088.6295.9954.1250.003
Selling & Marketing Expenses 0000000000000.001
SG&A 34.45225.70419.23914.80711.8458.7719.3298.91210.1088.6295.9954.1250.004
Other Expenses 00-0.055-0.058-0.101-0.050.1760.0320.0930.0070.0030.0010
Operating Expenses 111.55883.0353.50330.35937.43527.08826.37127.59435.55831.65921.68118.1190.016
Operating Income -111.558-83.03-53.503-194.976-37.435-27.088-26.371-27.094-35.558-31.659-21.681-18.119-0.016
Operating Income Ratio 0000000-54.18800000
Total Other Income Expenses Net 17.29810.1391.6690.0640.1350.7950.501-0.27-0.502-0.971-0.2030.0010
Income Before Tax -94.26-72.891-51.834-194.912-37.3-26.293-25.87-27.364-36.06-32.63-21.884-18.118-0.016
Income Before Tax Ratio 0000000-54.72800000
Income Tax Expense 00-1.669-164.739-0.236-0.050.6010.4940.930.7830.20900
Net Income -94.26-72.891-50.165-30.173-37.064-26.243-25.87-27.364-36.06-32.63-21.884-18.118-0.016
Net Income Ratio 0000000-54.72800000
EPS -1.67-2.42-3.43-3.38-12.12-14.06-30.71-75.73-133.31-243.45-151.53-125.45-0.108
EPS Diluted -1.67-2.42-3.43-3.38-12.12-14.06-30.71-75.73-133.31-243.45-151.53-125.45-0.108
EBITDA -111.558-83.03-53.503-194.976-37.435-26.267-25.651-26.598-34.828-31.459-21.43-17.799-15.342
EBITDA Ratio 0000000-53.19600000